Constellation cancer drug shows strong data, but skepticism may not fade

Constellation cancer drug shows strong data, but skepticism may not fade

STAT Plus: Constellation’s blood cancer drug shows strong results, but skepticism may not fade

By ADAM FEUERSTEIN

KEVIN MACKENZIE/UNIVERSITY OF ABERDEEN/WELLCOME

Critics say the myelofibrosis patients chosen to enroll in the study have less advanced disease, which makes it easier to show a spleen response.

READ MORE